US Patent

US10071085 — Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof

Formulation · Assigned to Bial Portela and Cia SA · Expires 2030-03-31 · 4y remaining

Vulnerability score 48/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects pharmaceutical formulations containing nitrocatechol derivatives and methods for making those formulations.

USPTO Abstract

The present disclosure relates to compositions and pharmaceutical formulations comprising at least one active pharmaceutical ingredient chosen from nitrocatechol derivatives of formula I as defined herein and salts, esters, hydrates, solvates and derivatives thereof and methods of making said compositions and pharmaceutical formulations.

Drugs covered by this patent

Patent Metadata

Patent number: US10071085
Jurisdiction: US
Classification: Formulation
Expires: 2030-03-31
Drug substance claim: No
Drug product claim: Yes
Assignee: Bial Portela and Cia SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.